Tag: motor neuron disease
Amyotrophic Lateral Sclerosis and Riluzole: How the First FDA-Approved Drug Slows ALS Progression
Riluzole is the first FDA-approved drug for ALS, modestly extending survival by 2-3 months. It works by reducing toxic glutamate activity in motor neurons. Despite side effects and limited efficacy, it remains the most prescribed ALS treatment worldwide.
Categories
- Health and Medicine (126)
- Health and Wellness (41)
- Womens Health (6)
- Mental Health (5)
- Mens Health (5)
- Nutrition and Supplements (4)
